Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference:
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com.A replay of the webcast will be available for 30 days.
About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via R&D innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
InvestorsLuis Sanay, CFA240-268-2022ir@novavax.com
MediaGiovanna Chandler844-264-8571media@novavax.com
https://mma.prnewswire.com/media/2343668/Novavax_High_Res_Logo.jpg
https://c212.net/c/img/favicon.png?sn=PH63984&sd=2025-09-03
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-cantor-global-healthcare-conference-302544402.html
SOURCE Novavax, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=PH63984&Transmission_Id=202509030800PR_NEWS_USPR_____PH63984&DateId=20250903